Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Scientists Crack The Code To Tamoxifen Resistance
http://www.medicalnewstoday.com/articles/129307.php
Cancer Research UK scientists have discovered the molecular basis for <a href="http://www.cancerhelp.org.uk/help/default.asp?page=3334" target="_blank" rel="nofollow">tamoxifen</a> response in <a href="http://info.
A New Way To Study How Breast Cancer Spreads Developed By Einstein Researchers
http://www.medicalnewstoday.com/articles/129290.php
In a breakthrough study appearing in advance online publication of <i>Nature Methods</i>, researchers at Albert Einstein College of Medicine of Yeshiva University describe for the first time a method of viewing individual breast cancer cells for several days at a time.
Many African-Americans Avoid Mammograms Due To Fear, Misconceptions About Screenings
http://www.medicalnewstoday.com/articles/129199.php
Training physicians and caregivers to improve cultural sensitivity and communication with economically disadvantaged African-American patients could influence these women to get mammograms that could save their lives, according to a new study in the <i>Journal of General Internal Medicine.
----------------------------------------------
** CANCER / ONCOLOGY News **
Scientists Crack The Code To Tamoxifen Resistance
http://www.medicalnewstoday.com/articles/129307.php
Cancer Research UK scientists have discovered the molecular basis for <a href="http://www.cancerhelp.org.uk/help/default.asp?page=3334" target="_blank" rel="nofollow">tamoxifen</a> response in <a href="http://info.
Assessing The Relative Risk Of Brain Cancer
http://www.medicalnewstoday.com/articles/129289.php
Doctors know that you're at a higher risk for breast, colon and prostate cancers if they've been found in your family. Brain cancer can now be placed on that same list, says a new study by Tel Aviv University and the University of Utah.
Common And Cancer Type-Specific Loss-of-Heterozygosity In Tumor Stroma And Epithelium Of Three Carcinoma Types Associated With Clinical Outcome
http://www.medicalnewstoday.com/articles/129276.php
A team of researchers led by Charis Eng, M.D., Ph.D., Chair and Director of Cleveland Clinic's Genomic Medicine Institute, has found that in-common genetic alterations in both cancerous cells and the surrounding normal-looking cells (called tumor microenvironment or stroma) play an important role in predicting and dictating the outcome of three cancer types: breast cancer (BC), prostate cancer (CaP) and head neck squamous cell carcinomas (HNSCC).
European Prospective Investigation Into Cancer And Nutrition Finds Large Waist Can Almost Double Risk Of Premature Death
http://www.medicalnewstoday.com/articles/129267.php
Having a large waistline can almost double your risk of dying prematurely even if your body mass index is within the 'normal' range, according to a new study of over 350,000 people across Europe, published in the <i>New England Journal of Medicine.
TNFerade™ Receives FDA Fast Track Designation For Treatment Of Pancreatic Cancer
http://www.medicalnewstoday.com/articles/129264.php
GenVec, Inc. (Nasdaq:GNVC) announced today that TNFerade™ has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for its proposed use in the treatment of locally advanced pancreatic cancer.
Study May Result In More Targeted Drugs For Gastrointestinal Stromal Tumors
http://www.medicalnewstoday.com/articles/129220.php
According to Oregon Health & Science University Knight Cancer Institute researchers, there is strong evidence that patients can have varying clinical responses to medications depending on the specific makeup of their cancer.
Saturated Fat Linked To Cancer Of The Small Intestine
http://www.medicalnewstoday.com/articles/129186.php
Findings published in the journal <a href="http://cancerres.aacrjournals.org/" target="_blank" rel="nofollow"><i>Cancer Research,</i></a> a journal of the American Association for Cancer Research, identify dietary intake of saturated fats as a possible risk factor for cancer of the small intestine, advancing the understanding of cancer development in this and other areas of the digestive tract.
Potential Pharmaceutical Royalties To Be Donated To Madagascar
http://www.medicalnewstoday.com/articles/129182.php
The National Institutes of Health has renewed a five-year research grant for a total of $2.5 million to an international biodiversity group lead by David G.I. Kingston, University Distinguished Professor of Chemistry at Virginia Tech.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Making HPV Vaccination Mandatory Is Unwarranted And Unwise
http://www.medicalnewstoday.com/articles/129180.php
The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus, the most common sexually transmitted infection in the world. The vaccine also prevents against cervical cancer.
----------------------------------------------
** COLORECTAL CANCER News **
Saturated Fat Linked To Cancer Of The Small Intestine
http://www.medicalnewstoday.com/articles/129186.php
Findings published in the journal <a href="http://cancerres.aacrjournals.org/" target="_blank" rel="nofollow"><i>Cancer Research,</i></a> a journal of the American Association for Cancer Research, identify dietary intake of saturated fats as a possible risk factor for cancer of the small intestine, advancing the understanding of cancer development in this and other areas of the digestive tract.
----------------------------------------------
** LUNG CANCER News **
Large International Study Identifies Genetic Susceptibility To Lung Cancer
http://www.medicalnewstoday.com/articles/129299.php
In a paper to be published in <i>Nature Genetics</i> on 2nd November, a worldwide consortium of investigators present a major breakthrough for understanding the genetic basis of lung cancer. The results are based on the largest genetic study of lung cancer ever conducted, and was organised by the International Agency for Research on Cancer (IARC, Lyon, France), the Centre National de Génotypage (CNG, Evry, France), with support from the Institut National du Cancer (Paris, France).
Phase 2 Study Of IMC-1121B In First-Line Treatment Of Advanced Non-Small Cell Lung Cancer Starts Patient Enrollment
http://www.medicalnewstoday.com/articles/129261.php
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed Phase 2 clinical trial of IMC-1121B in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC) has opened for patient enrollment.
Lung Cancer Rates Dropping But Hospitalization Rates Remain Constant, USA
http://www.medicalnewstoday.com/articles/129192.php
Hospital admissions for lung cancer remained relatively stable - at roughly 150,000 a year between 1995 and 2006 - despite a steady decline in the number of Americans diagnosed with the disease, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
Survey Shows Lung Cancer Patients Blamed For Their Diagnosis
http://www.medicalnewstoday.com/articles/129181.php
Survey results released today show that the general population blames lung cancer patients for their diagnosis, confirming the stigma that patients reportedly feel. Findings also demonstrate a lack of public support for patients and a need for greater research for the number one cancer killer.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
INNO-406 Demonstrates Positive Clinical Responses In Phase 1 Trial In Patients With Chronic Myeloid Leukemia
http://www.medicalnewstoday.com/articles/129240.php
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that INNO-406, CytRx's potent, orally available, rationally designed, dual Bcr-Abl and Lyn-kinase inhibitor, demonstrated clinical responses in patients with Chronic Myeloid Leukemia (CML).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
No news for this category today.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment